News
Metapneumovirus infections clinically indistinguishable from flu, RSV
November 17, 2020
Those at risk for severe or fatal metapneumovirus infections include frail elderly and patients with cardiovascular disease or compromised immunity.
News
Cardiac arrest in COVID-19 pandemic: ‘Survival is possible’
November 17, 2020
Results of new studies of in- and out-of-hospital cardiac arrest underline that, despite lower survival rates during the pandemic, rates are “not zero,” and response is “not futile.”
News
In those with obesity, will losing weight cut COVID-19 severity?
November 17, 2020
“To think excess weight may also be detrimental to acute effects of a novel virus running amok in the world has focused minds on obesity in a manner not seen before.”
![1]()
News
New-onset AFib common but unrecognized in the month after cardiac surgery
November 17, 2020
Results of SEARCH-AF trial show one in five cardiac surgery patients with no history of atrial fibrillation develop it within 30 days post discharge.
![1]()
News
Empagliflozin favorably reshaped left ventricles in HFrEF patients
November 15, 2020
Results from two separate randomized studies showed empagliflozin treatment of patients with HFrEF produced significant heart remodeling.
![1]()
News
Intravenous iron reduces HF readmissions: AFFIRM-AHF
November 14, 2020
The results are likely to change heart failure guidelines, which currently give a lukewarm recommendation for intravenous iron in the US, experts say.
![1]()
News
GALACTIC-HF: New ‘myotropic’ drug class shows modest HFrEF benefit
November 13, 2020
Omecamtiv mecarbil safely met its primary efficacy endpoint in patients with heart failure with reduced ejection fraction in GALACTIC-HF, but with a modest effect.
News
Escalate HIV adherence strategies amid COVID-19
November 13, 2020
Virtual care is not meeting the needs of people with HIV who struggled with viral suppression even before the COVID-19 pandemic.
![1]()
News
What happened to melanoma care during COVID-19 sequestration
November 11, 2020
Preliminary evidence indicates delayed diagnosis and treatment measurably worsened outcome indicators.
![1]()
News
Higher cardiovascular risks in Kawasaki disease persist 10-plus years
November 8, 2020
Researchers evaluated the incidence of myocardial infarction, stroke, death, and more in a follow-up study of Kawasaki disease survivors, compared to unaffected children.
